Asia Pacific Flowable Hemostats Market Forecast to 2028
Asia Pacific Flowable Hemostats Market Forecast to 2028 – Regional Analysis – by Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, and Combination Hemostats), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Orthopedic Surgery, Neuro & Spine Surgery, and Others), and End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Number of Hospitals and Surgical Centers Fuels Asia Pacific Flowable Hemostats Market
Injuries are still a significant concern to public health. An increase in global trauma and accident cases is a major driver of the Asia Pacific flowable hemostats market. According to World Health Organization (WHO), annually approximately 1.3 million people cut short their lives because of a road traffic crash. Between 20 to 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury. Globally, hemorrhage or excessive bleeding is responsible for over one-third of pre-hospital deaths and over 40% of deaths within the first 24 hours. The number of surgeries is rising owing to the increasing musculoskeletal disorders related with sports, occupational injuries, and age-related dysfunction. However, a substantial proportion of health gains are lost owing to sports-related injuries. The National Library of Medicine report states China as a large base of patients agonizing traumatic brain injury (TBI) compared to other countries, making this condition a major public health concern. Thus, increasing number of injuries and surgical procedures are responsible for the high adoption of flowable hemostats, thereby driving the market’s growth during the forecast period.
Asia Pacific Flowable Hemostats Market Overview
The Asia Pacific flowable hemostats market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of market in the Asia Pacific region is expected to grow at a faster pace owing to investments made in the infrastructure development of the healthcare sector, rising number of surgical procedures, growing emphasis on providing superior surgical outcomes, and favorable regulatory approvals. China holds a considerable share in the Asia Pacific flowable hemostats market. The market is expected to grow owing to the growing emphasis on providing superior surgical care, and the growing demand for modern healthcare instruments. The rise in the prevalence of bleeding disorders has paved the way for the design, development, and piloting of flowable hemostats. According to a Hemophilia Treatment Center Collaboration Network of China (HTCCNC) study, HTCCNC identified 17,779 patients with Hemophilia A from 2007 to 2019. Patients were predominantly male (99.99%), and 28.3% had a known family history of hemophilia. Among patients with lab-measured disease severity (N = 13,116), 6,519 had severe HA (49.7%), 4,788 had moderate HA (36.5%), and 1,809 had mild HA (13.8%). Thus, rising incidences of hemophilia will increase the demand for flowable hemostats during the forecast period.
Asia Pacific Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Flowable Hemostats Market Segmentation
The Asia Pacific flowable hemostats market is segmented into material , product, application, end user, and country .
Based on material, the Asia Pacific flowable hemostats market is bifurcated into bovine gelatin and porcine gelatin. The bovine gelatin segment held a larger share of the Asia Pacific flowable hemostats market in 2022.
In terms of product , the Asia Pacific flowable hemostats market is segmented into combination hemostats , passive hemostats, and active hemostats . The combination hemostats segment held the largest share of the Asia Pacific flowable hemostats market in 2022.
Based on application , the Asia Pacific flowable hemostats market is categorized into general surgery , cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others . The general surgery segment held the largest share of the Asia Pacific flowable hemostats market in 2022.
Based on end user , the Asia Pacific flowable hemostats market is segmented into hospitals and clinics , ambulatory surgery centers, and others . The hospitals and clinics segment held the largest share of the Asia Pacific flowable hemostats market in 2022.
By country, the Asia Pacific flowable hemostats market is categorized int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific flowable hemostats market in 2022.
Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the Asia Pacific flowable hemostats market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Asia Pacific flowable hemostats market was valued at US$ 176.64 million in 2022 and is expected to reach US$ 275.19 million by 2028, registering a CAGR of 7.7% from 2022 to 2028. Increasing number of hospitals and surgical centers and rising geriatric population are among the critical factors attributed to the Asia Pacific flowable hemostats market expansion.
The number of hospitals and surgical centers is increasing rapidly in developed and emerging regions. Such growth accelerates demand for surgical equipment (including medical devices and hemostat products) for lately established surgical centers and hospitals. Also, in the past decade, countries such as India and China have observed notable improvements in healthcare infrastructure. In June 2019, the Indian Ministry of Health and Family Welfare announced the inauguration of 22 new AIIMS hospitals across the country. The Statistics Bureau and Ministry of Internal Affairs and Communications report states that, as of October 2019, the number of hospitals in Japan accounted 8,300, while the number of hospital beds accounted about 1,529,215 (1,212.1 per 100,000 people). Furthermore, the growth in the healthcare sector offers lucrative opportunities for the flowable hemostats market. The healthcare industry has been encountering a rapid transformation in recent years. Various countries across the globe have favored advanced technologies in healthcare. With the need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being referred to in the healthcare systems, especially in emerging economies. Some of the primary factors, such as rising incidences of chronic illnesses, an increase in the aging population, and pediatric care, are helping boost the growth of the healthcare industry. With rising technical procedures, the effectiveness of topical hemostats may help improve clinical outcomes. Thus, the ideal topical hemostats would offer authentic and prompt bleeding control. Such significant growth in the number of hospitals and surgical centers demands high adoption of flowable hemostat products, ultimately offering lucrative growth opportunities for the market’s growth during the coming years.
On the contrary, shortage of skilled professionals and poor reimbursement policies hamper the Asia Pacific flowable hemostats market.
Based on material, the Asia Pacific flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held 62.3% share of Asia Pacific flowable hemostats market in 2022, amassing US$ 109.98 million. It is projected to garner US$ 173.45 million by 2028 to expand at 7.9% CAGR during 2022-2028.
In terms product, the Asia Pacific flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held 58.3% share of Asia Pacific flowable hemostats market in 2022, amassing US$ 102.97 million. It is projected to garner US$ 163.49 million by 2028 to expand at 8.0% CAGR during 2022-2028.
Based on application, the Asia Pacific flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held 32.6% share of Asia Pacific flowable hemostats market in 2022, amassing US$ 57.50 million. It is projected to garner US$ 94.93 million by 2028 to expand at 8.7% CAGR during 2022-2028.
Based on end user, the Asia Pacific flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held 64.6% share of Asia Pacific flowable hemostats market in 2022, amassing US$ 114.03 million. It is projected to garner US$ 176.25 million by 2028 to expand at 7.5% CAGR during 2022-2028.
By country, the Asia Pacific flowable hemostats market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 31.4% share of Asia Pacific flowable hemostats market in 2022. It was assessed at US$ 55.50 million in 2022 and is likely to hit US$ 90.75 million by 2028, exhibiting a CAGR of 8.5% during 2022-2028.
Key players operating in the Asia Pacific flowable hemostats market Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences, among others.
In Dec-19, Johnson & Johnson’s Ethicon unit has launched its blood-stopping protein spray, designed to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures. According to Ethicon, it is the first fibrin sealant designed to be used without a gas propellant. Delivered in a pre-filled syringe, the spray is designed to rapidly adhere and form a clot over the bleed and has shown clinical success in high-risk patients-such as those with multiple factors including bleeding disorders, diabetes or organ failure, or patients taking blood thinners or antiplatelet therapies.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific flowable hemostats market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 the Research Team Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Flowable Hemostats Market – By Material
1.3.2 Asia Pacific Flowable Hemostats Market – By Product
1.3.3 Asia Pacific Flowable Hemostats Market – By Application
1.3.4 Asia Pacific Flowable Hemostats Market – By End User
1.3.5 Asia Pacific Flowable Hemostats Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Flowable Hemostats Market – Market Landscape
4.1 Overview
4.1.1 Asia Pacific PEST Analysis
4.2 Asia Pacific Experts Opinion
5. Asia Pacific Flowable Hemostats Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Injuries and Surgical Procedures
5.1.2 Rising Geriatric Population
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
5.3 Market Opportunities
5.3.1 Increasing Number of Hospitals and Surgical Centers
5.4 Future Trends
5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
5.5 Impact Analysis
6. Flowable Hemostats Market – Asia Pacific Analysis
6.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis
6.1.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis
7. Asia Pacific Flowable Hemostats Market Analysis – By Material
7.1 Asia Pacific Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
7.2 Bovine Gelatin
7.2.1 Overview
7.2.2 Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
7.3 Porcine Gelatin
7.3.1 Overview
7.3.2 Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Flowable Hemostats Market- By Product
8.1 Overview
8.2 Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
8.3 Combination Hemostat
8.3.1 Overview
8.3.2 Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Passive Hemostat
8.4.1 Overview
8.4.2 Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Active Hemostat
8.5.1 Overview
8.5.2 Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Flowable Hemostats Market- By Application
9.1 Overview
9.2 Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
9.3 General Surgery
9.3.1 Overview
9.3.2 General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Surgery
9.4.1 Overview
9.4.2 Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Vascular Surgery
9.5.1 Overview
9.5.2 Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopedic Surgery
9.6.1 Overview
9.6.2 Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Neuro and Spine Surgery
9.7.1 Overview
9.7.2 Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Flowable Hemostats Market Analysis – By End User
10.1 Overview
10.2 Asia Pacific Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Asia Pacific Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgery Centers
10.4.1 Overview
10.4.2 Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Asia Pacific Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
11. Asia Pacific Flowable Hemostats Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Asia Pacific: Flowable Hemostats Market
11.1.1 Overview
11.1.2 Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
11.1.2.1 China: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
11.1.2.1.2 China: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3 China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4 China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 China: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.2 Japan: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
11.1.2.2.2 Japan: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 Japan: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.3 India: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
11.1.2.3.2 India: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 India: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.4 South Korea: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 South Korea: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 South Korea: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.4.3 South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.4.4 South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.4.5 South Korea: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.5 Australia: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.1 Australia: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.2 Australia: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.5.3 Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.5.4 Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.5.5 Australia: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.6 Rest of Asia Pacific: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.1 Rest of Asia Pacific: Flowable Hemostats Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.2 Rest of Asia Pacific: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
11.1.2.6.3 Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
11.1.2.6.4 Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.2.6.5 Rest of Asia Pacific: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
12. Flowable Hemostats Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Flowable Hemostats Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Baxter International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Teleflex Incorporated
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Aegis Lifesciences
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 Asia Pacific Glossary of Terms
LIST OF TABLES
Table 1. China: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 2. China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 3. China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. China: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 11. India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 12. India: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 13. South Korea: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Australia: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 18. Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 19. Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 20. Australia: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia Pacific: Flowable Hemostats Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia Pacific: Flowable Hemostats Market, End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments in the Flowable Hemostats Market
Table 26. Inorganic Developments in the Flowable Hemostats Market
Table 27. Asia Pacific Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Flowable Hemostats Market Segmentation
Figure 2. Asia Pacific Flowable Hemostats Market, By Country
Figure 3. Asia Pacific Flowable Hemostats Market Overview
Figure 4. Bovine Gelatin Holds Maximum Share in Asia Pacific Flowable Hemostats Market
Figure 5. Asia Pacific Flowable Hemostats Market, by Country (US$ Million)
Figure 6. Asia Pacific Flowable Hemostats Market, Market Attractiveness
Figure 7. Asia Pacific: PEST Analysis
Figure 8. Asia Pacific Experts Opinion
Figure 9. Impact Analysis
Figure 10. Asia Pacific Flowable Hemostats Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Asia Pacific Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
Figure 12. Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 13. Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
Figure 15. Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 16. Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 17. Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
Figure 19. General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 22. Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
Figure 26. Hospitals and Clinics: Asia Pacific Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Asia Pacific Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 30. Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
Figure 31. China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 32. Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 33. India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 34. South Korea: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 35. Australia: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 36. Rest of Asia Pacific: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 37. Growth Strategies in the Flowable Hemostats Market (%)
The List of Companies – Asia Pacific Flowable Hemostats Market
1. Baxter International Inc
2. Ethicon (Johnson & Johnson)
3. Pfizer Inc.
4. Teleflex Incorporated
5. 3-D Matrix Medical Technology
6. Aegis Lifesciences
You must be logged in to post a review.
Reviews
There are no reviews yet.